You are here

Taste Test of a New Formulation of Sildenafil (Revatio)

Last updated on April 10, 2018

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Cambridge, Massachusetts, 02140 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
None Volunteer
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of hypersensitivity to test compounds or excipients.

NCT00768573
Pfizer
Completed
Taste Test of a New Formulation of Sildenafil (Revatio)

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Healthy Volunteers
NCT03184168
Males
18+
Years
Madison, Wisconsin
Healthy Volunteers
NCT03351751
All Genders
18+
Years
New Haven, Connecticut
None Volunteer
NCT00768573
All Genders
18+
Years
Cambridge, Massachusetts
Taste Test of a New Formulation of Sildenafil (Revatio)
A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®
taste of formulation
taste test None
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Healthy volunteers
None Volunteer
Drug: sildenafil
Oral suspension of sildenafil.
1. Taste test
Not Specified
Intervention: Drug: sildenafil
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4
January 2008
January 2008   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy

Exclusion Criteria:

  • History of hypersensitivity to test compounds or excipients.
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00768573
A1481257
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2015

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now